Longevity Treatments Explained: What Is Available and What Should You Consider?

A responsible longevity programme should begin with medical history, health priorities and an honest discussion of the evidence behind each proposed treatment.

Interest in longevity medicine has grown rapidly, but the term can mean very different things depending on who uses it. For some people, longevity care is an extension of preventive medicine built around screening, exercise, nutrition, sleep and management of established health risks. For others, it includes genetic testing, extensive biomarker panels, hormone treatment, intravenous nutrients, peptides or regenerative therapies marketed around cellular ageing.

Clinics such as Phuket Longevity Institute bring several of these approaches together within personalised programmes. According to its website, the institute offers diagnostics, genetic and metabolic testing, IV infusions, peptide therapy and cell- or exosome-based services.

However, the availability of several treatments at one clinic does not mean they all have the same level of evidence, approval or suitability. Each intervention should be assessed separately.

No credible provider can guarantee a longer lifespan, stop ageing or reverse it completely. A more useful goal is improving healthspan: the period of life spent in good physical, cognitive and functional health.

Quick Answer

The strongest foundations for healthy ageing remain preventive healthcare, physical activity, nutritious food, restorative sleep, social connection and appropriate management of blood pressure, cholesterol, diabetes and other established risks.

Some additional treatments may be appropriate for diagnosed medical conditions. Others—including many compounded peptides, wellness IV infusions, exosome products and cell-based “anti-ageing” interventions—have limited or uncertain evidence for extending lifespan in otherwise healthy adults.

Before starting any longevity treatment, ask what specific problem it addresses, how strong the evidence is, whether it is approved for that use, what risks it carries and how the provider will monitor you.

Key Takeaways

• Longevity medicine should focus on health and function, not promises of reversing age.

• A medical history and risk assessment should come before advanced testing or treatment.

• More testing is not automatically better.

• Genetic results often indicate probability rather than certainty.

• Hormone treatment should address a recognised clinical need, not an arbitrary “optimal” number.

• IV nutrients are medically useful in certain situations but have not been shown to extend lifespan in healthy people.

• Peptides differ significantly; evidence for one cannot be applied to another.

• Many cell and exosome treatments marketed for longevity remain experimental.

• Exercise, nutrition, sleep and preventive care remain the most dependable starting points.

• People travelling for longevity care need a clear follow-up and emergency plan.

Table of Contents

1. What Does Longevity Medicine Mean?

2. Start With Preventive Health and a Proper Assessment

3. Biomarker, Genetic and Metabolic Testing

4. Hormone Assessment and Treatment

5. IV Nutrient Therapy

6. Peptide Treatments

7. Regenerative, Cell-Based and Exosome Therapies

8. Exercise, Nutrition, Sleep and Recovery Still Matter Most

9. How to Choose a Longevity Clinic

10. Travelling Abroad for Longevity Treatment

Frequently Asked Questions

1. What Does Longevity Medicine Mean?

Longevity medicine is not one recognised treatment or a single clinical specialty. The term is used broadly to describe healthcare intended to preserve physical and cognitive function, reduce avoidable disease risks and support wellbeing as people age.

The World Health Organization defines healthy ageing as developing and maintaining the functional ability that enables wellbeing in older age. This includes being able to meet basic needs, make decisions, remain mobile, maintain relationships and contribute to society.

That definition is more useful than focusing on a biological-age score or an unproven promise to slow ageing. A longevity plan should ideally help a person maintain abilities that matter in everyday life, such as:

• Walking comfortably

• Preserving strength and balance

• Thinking and remembering clearly

• Sleeping adequately

• Maintaining independence

• Managing existing health conditions

• Participating in work, family and social life

A programme can include innovative treatments, but innovation should not replace sound medical reasoning.

Myth vs Fact

Myth: Longevity medicine can reverse ageing and guarantee extra years of life.

Fact: No treatment can guarantee how long someone will live. Responsible longevity care focuses on reducing recognised risks and maintaining health and function.

2. Start With Preventive Health and a Proper

Assessment

The foundation of longevity care is not an advanced infusion or experimental therapy. It is a clear understanding of the person’s current health.

An appropriate assessment may review:

• Medical and family history

• Current medications and supplements

• Symptoms and diagnosed conditions

• Blood pressure

• Cardiovascular and metabolic risks

• Sleep quality

• Physical activity and strength

• Nutrition and alcohol intake

• Smoking or nicotine use

• Mental wellbeing

• Vaccination history

• Age-appropriate health screening

The clinician should also ask what the person hopes to achieve. Wanting more energy, improving athletic recovery and reducing cardiovascular risk are different objectives that require different assessments.

Existing symptoms should not automatically be attributed to ageing. Fatigue, sleep disruption, weight changes, reduced exercise tolerance or cognitive difficulties can have many possible causes. These may include medication effects, anaemia, thyroid disorders, sleep apnoea, depression or another health condition requiring conventional evaluation.

Preventive care also needs to remain connected to a person’s usual GP or medical team. A short longevity programme should complement—not fragment—existing healthcare.

💡 Expert Tip: Before attending a longevity consultation, prepare a list of your medications, supplements, diagnoses, previous test results and main health priorities. This can reduce duplicated testing and help the clinician identify possible interactions.

3. Biomarker, Genetic and Metabolic Testing

Some longevity clinics use extensive panels covering cardiovascular markers, blood sugar regulation, hormones, micronutrients and other biomarkers. Genetic or metabolic tests may also be offered to explore inherited tendencies, nutrient processing, medication response or disease susceptibility.

The appeal is understandable. Personalised recommendations appear more precise than general advice. However, a test is useful only when it answers a meaningful question and can influence an appropriate decision.

Before agreeing to a test, ask:

• What clinical question will this result answer?

• Is the test validated for this purpose?

• Could illness, medication, exercise or fasting affect the result?

• What will change if the result is high or low?

• Is repeat testing necessary?

• Who will interpret the findings?

• Could the test identify unrelated or uncertain information?

Broader panels increase the likelihood of finding a result outside a laboratory reference range, even in someone who is well. An isolated abnormal value does not always indicate disease. Results should be interpreted alongside symptoms, medical history and other findings.

Genetic results also commonly describe probabilities rather than certain outcomes. The National Human Genome Research Institute explains that direct-to-consumer genetic testing can have limitations involving clinical validity, interpretation and the scope of the variants tested.

A qualified clinician or genetic counsellor may be needed when a result could affect medical decisions or have implications for relatives.

📊 Evidence Snapshot: Longevity Testing

Type of assessment	Potential value	Important limitation
Blood pressure and established cardiovascular assessment	Identifies recognised, modifiable health risks	Requires interpretation in clinical context
Blood glucose and lipid testing	Can support metabolic and cardiovascular care	Testing frequency should reflect individual risk
Broad micronutrient panels	May identify selected deficiencies	Abnormal results may be incidental or difficult to interpret
Genetic testing	Can identify certain inherited risks or medication-related variants	Many findings have limited predictive value
Biological-age testing	May estimate aspects of ageing using selected algorithms	Different tests are not interchangeable and clinical usefulness remains uncertain
Wearable-device data	Can help identify patterns in activity or sleep	Consumer devices do not replace clinical diagnosis

4. Hormone Assessment and Treatment

Hormonal changes can affect energy, sleep, sexual function, menstrual patterns, mood and body composition. This is one reason hormone testing frequently appears in longevity programmes.

Testing may be appropriate when symptoms or medical history suggest a particular hormonal condition. However, hormone treatment should not become a routine anti-ageing intervention for every adult.

The important distinction is between:

• Treating a diagnosed deficiency or recognised condition

• Treating symptoms following an appropriate assessment

• Attempting to push laboratory results towards a clinic-defined “optimal” level without an established indication

Prescription hormones can cause adverse effects and may be unsuitable for people with certain health histories. The appropriate treatment, dose and delivery method depend on the individual.

For example, the NHS explains that hormone replacement therapy may help relieve menopausal symptoms and prevent osteoporosis in suitable patients, but benefits and risks need to be considered.

Before accepting hormone treatment, ask:

• Which hormone is being tested?

• Do my symptoms and results support a recognised diagnosis?

• Could medication, illness or testing time affect the result?

• What benefits are reasonably expected?

• What risks and alternatives should I consider?

• How will the dose and safety be monitored?

• What happens if I stop treatment?

Readers can also explore our guide to common misconceptions about HRT for further evidence-based context.

5. IV Nutrient Therapy

Intravenous vitamin and nutrient infusions are common in wellness and longevity settings. Their appeal comes partly from delivering substances directly into the bloodstream instead of through the digestive system.

IV therapy has established medical uses. It may be used to provide fluids, medicines or particular nutrients when there is an appropriate clinical reason. That does not mean a general wellness infusion will slow ageing or improve longevity in someone without a diagnosed need.

The relevant questions are not simply whether an infusion contains vitamins, but:

• Why is an IV route necessary?

• Is there evidence of a deficiency or clinical need?

• What ingredients and doses are included?

• Could any ingredient interact with medications?

• Is kidney, heart or liver function relevant?

• Who prescribes and administers the infusion?

• What happens if an adverse reaction occurs?

Potential risks include infection, bruising, inflammation of the vein, fluid imbalance, allergic reactions and complications from inappropriate ingredients or doses. Risk can differ considerably according to the formulation and the person receiving it.

A provider should not describe an infusion as a universal detoxification, immunity or anti-ageing treatment without appropriate evidence. Patients should know exactly what they are receiving and why.

6. Peptide Treatments

Peptides are short chains of amino acids that perform many different functions in the body.

Some authorised medicines are peptide-based and have established uses. However, the broad word “peptide” is also used to market numerous compounds for recovery, fat loss, muscle growth, sleep, cognition and longevity.

Evidence for one peptide cannot be transferred to another. Each substance has its own pharmacology, research history, quality requirements and regulatory status.

Before considering peptide therapy, ask for:

• The exact generic name

• The intended medical purpose

• Whether it is authorised for that use

• The quality and source of the product

• Human clinical evidence

• Known and uncertain risks

• Possible medication interactions

• The proposed dose and duration

• Monitoring and stopping criteria

This is particularly important with compounded products. The US Food and Drug Administration has identified potential safety concerns involving several substances used in compounding, including certain peptides promoted in wellness settings. For some, the agency reports limited human safety information or concerns involving impurities, immune reactions and other adverse effects.

A personalised protocol is not automatically an evidence-based one. Personalisation should mean adapting a justified treatment to the patient—not selecting an unproven substance and presenting uncertainty as precision.

7. Regenerative, Cell-Based and Exosome Therapies

Regenerative medicine includes legitimate, established treatments as well as experimental interventions. The term alone does not reveal whether a particular therapy is approved, proven or appropriate.

Cell-based and exosome products are sometimes marketed for:

• Joint or tissue recovery

• Neurological health

• Immune “balance”

• Skin or hair rejuvenation

• Reduced inflammation

• General anti-ageing effects

These uses should be evaluated individually. A treatment established for one narrowly defined medical condition should not be assumed to work for unrelated longevity goals.

Before considering a cell- or exosome-based intervention, ask:

• What precisely is being administered?

• What is the biological source?

• How is it collected, processed and stored?

• Is it authorised for the proposed use?

• Has it been studied in controlled human trials?

• What short- and long-term risks are known?

• Is the treatment part of a registered clinical trial?

• Who manages complications?

• What follow-up is required?

The FDA warns that many regenerative medicine products, including stem-cell and exosome products, have been marketed without approval for conditions they have not been shown to treat safely or effectively.

“Regenerative” is therefore not a synonym for harmless or proven. Where evidence remains experimental, the provider should say so plainly. Diabetes provides a useful example, because insulin and experimental stem-cell treatments have very different evidence, regulatory status and long-term outcomes.

8. Exercise, Nutrition, Sleep and Recovery Still Matter Most

Advanced interventions attract attention, but the less dramatic components of longevity care remain central.

Regular physical activity supports cardiovascular health, strength, mobility, balance and independence. A balanced programme will often include:

• Aerobic movement

• Resistance training

• Balance exercises

• Mobility work

• Recovery time appropriate to the person’s health and fitness

Nutrition should be based on overall dietary quality rather than a long list of supplements.

Adequate protein, fibre, fruit, vegetables and minimally processed foods may support muscle, metabolic and digestive health. Individual needs still differ, particularly where kidney disease, diabetes, allergies or other medical conditions are present.

Sleep also deserves proper assessment. Persistent snoring, breathing pauses, insomnia or

severe daytime sleepiness may need medical evaluation rather than another supplement.

Social connection, mental wellbeing, hearing, vision and oral health can also influence independence and quality of life. Longevity is not only about laboratory markers; it is about maintaining the ability to participate in daily life.

For related guidance, readers can explore our Nutrition Hub and articles on healthy ageing.

📊 Evidence Snapshot: Treatment Categories

Approach	Evidence position	What to consider
Preventive care and management of established risks	Strong foundation	Screening should reflect age, history and recognised guidance
Exercise, nutrition and sleep support	Strong foundation	Plans should be realistic and individualised
Hormone treatment for an established indication	Evidence-based in appropriate patients	Requires assessment, monitoring and discussion of risks
Broad hormone “optimisation” without a diagnosis	Uncertain	Benefits may be overstated and risks underexplained
IV nutrients for a documented medical need	Established in selected circumstances	The IV route must have a clinical purpose
General longevity IV infusions	Limited evidence for lifespan extension	Ingredients, doses and risks vary
Approved peptide medicines	Substance- and condition-specific	Evidence cannot be generalised to all peptides
Compounded or unapproved longevity peptides	Often limited or uncertain	Quality, safety and regulatory status require scrutiny
Cell and exosome therapies for general longevity	Experimental for many promoted uses	Ask about approval, trials, product source and follow-up

Strength, balance and regular movement remain central components of maintaining function with age.

9. How to Choose a Longevity Clinic

A polished clinic, expensive testing and scientific language do not by themselves establish quality. The most useful questions concern clinical responsibility and transparency.

Check:

• Who performs the initial assessment

• Who prescribes each treatment

• Which professional licences they hold

• Whether clinicians are licensed in the location where care is provided

• How diagnoses and recommendations are documented

• Whether your regular doctor can receive the results

• How treatment risks and uncertainties are explained

• Whether emergency equipment and trained staff are available

• How side effects are reported and managed

• Whether the provider is willing to recommend no treatment

Be cautious when a clinic:

• Guarantees age reversal or a longer life

• Uses one protocol for nearly every patient

• Recommends treatment before reviewing medical history

• Cannot provide the exact name of a substance

• Describes all treatments as clinically proven

• Pressures patients to buy quickly

• Dismisses questions about regulation

• Advises stopping prescribed medication without involving the original prescriber

• Offers no meaningful follow-up

💡 Expert Tip: Ask the clinic to separate its recommendations into three categories: established care, emerging care and experimental treatment. This makes it easier to understand where evidence is strong and where uncertainty remains.

10. Travelling Abroad for Longevity Treatment

Some adults travel abroad for diagnostic or longevity programmes because of convenience, privacy, cost or access to treatments not available at home.

Medical travel requires additional planning. Before booking, consider:

• Whether the proposed treatment is approved in your home country

• How the overseas clinic is regulated

• Whether professional licences can be verified

• Language and informed-consent procedures

• Infection-control standards

• Emergency hospital arrangements

• Travel risks following an infusion or procedure

• How records will be shared with your usual doctor

• Who provides follow-up after you return home

• What happens if complications appear weeks later

Some centres advertise several diagnostic and treatment options within one programme. This may make coordination more convenient, but patients should still assess every recommended test and intervention independently. A package should not replace informed consent for each component.

Ask for a written plan listing the exact tests, substances, doses, costs, risks and follow-up arrangements before travelling or paying a deposit.

11. Questions to Ask Before Starting Treatment

Use this checklist during a consultation:

• What specific health issue or goal is this treatment addressing?

• Do I have a recognised indication for it?

• What evidence supports its use in someone like me?

• Is it authorised for this particular purpose?

• Is the recommendation based on symptoms, validated testing or a standard package?

• What benefits are realistic?

• What remains uncertain?

• What are the common and serious risks?

• Could it interact with my medicines or supplements?

• Are there simpler, safer or better-established alternatives?

• Who is responsible for prescribing and monitoring it?

• How will success be measured?

• What would cause the treatment to be adjusted or stopped?

• What follow-up is included?

• Will my regular doctor receive the records?

• What is the complete cost?

A reputable provider should welcome these questions and explain uncertainty without becoming defensive.

Longevity Care Should Be Personal, Not Formulaic

There is no single longevity protocol suitable for everyone. Age, health history, medication, genetics, fitness, sleep, nutrition and personal priorities all influence what may be useful.

For one person, the most valuable intervention might be better blood-pressure control. For another, it may be strength training, treatment for sleep apnoea, support through menopause or improved diabetes management.

Some people may benefit from additional diagnostics or specialist care. Emerging treatments may be reasonable in carefully selected circumstances, particularly within properly regulated research. Others may offer high costs and persuasive marketing without clear evidence of meaningful benefit.

Personalised care should identify genuine priorities and avoid unnecessary treatment. It should not simply attach an individual’s name to a predetermined package.

Frequently Asked Questions

What is the difference between lifespan and healthspan?

Lifespan is the total length of a person’s life. Healthspan generally refers to the years spent in relatively good health and with meaningful physical, cognitive and functional ability.

Can a longevity clinic determine my biological age?

Some clinics use blood markers, genetic information or mathematical models to estimate aspects of biological ageing. Different tests may produce different results, and their ability to guide individual treatment is still developing. A biological-age score should not replace established medical assessment.

Do IV vitamin infusions slow ageing?

IV nutrients have important medical uses when clinically indicated. There is not currently reliable evidence that general wellness infusions extend lifespan in otherwise healthy people.

Are peptide treatments safe?

Some peptide-based medicines have well-established uses. Other peptides marketed for anti-ageing, recovery or performance have limited human evidence or uncertain regulatory status. Safety must be assessed for the exact substance, dose, route and individual.

Is hormone therapy an anti-ageing treatment?

Hormone treatment can be appropriate for recognised conditions or symptoms, including menopausal symptoms in suitable patients. It should not be prescribed routinely to every adult as a way to prevent ageing.

Are stem-cell or exosome treatments proven for longevity?

Many cell- and exosome-based treatments promoted for general longevity remain experimental. Patients should confirm regulatory status, human evidence, product source and possible risks.

What should a basic longevity assessment include?

It may include medical and family history, medication review, blood pressure, cardiovascular and metabolic risk, sleep, exercise, nutrition, mental wellbeing and appropriate screening. The exact assessment should reflect the individual.

Can massage or acupuncture extend lifespan?

Massage and acupuncture should not be presented as treatments that extend lifespan. Some people use complementary therapies to support relaxation, symptom management or general wellbeing alongside appropriate healthcare.

Final Thoughts

Longevity medicine is likely to evolve as research develops, but newer does not always mean better. The challenge is distinguishing useful innovation from attractive marketing.

The strongest programme is not necessarily the one offering the most tests or treatments. It is the one that begins with individual health priorities, uses appropriate diagnostics, explains evidence honestly and provides qualified clinical oversight and follow-up.

Ultimately, longevity care should help people make better-informed decisions about their health today—not encourage them to chase guarantees about how long they will live tomorrow.

Continue Exploring the Healthy Ageing Hub

Learn more about maintaining physical function, cognitive wellbeing and independence through our healthy-ageing resources.

Related A to Zen Hubs

• Hormone Health Hub

• Nutrition Hub

• Men’s Health Hub

• Women’s Health Hub

Related Complementary Services

These services are not anti-ageing treatments and do not claim to extend lifespan. Some people use them as part of a broader wellbeing routine:

• Massage Therapy

• Acupuncture

• Manual Lymphatic Drainage

• Deep Tissue Massage

References

• World Health Organization: Healthy Ageing and Functional Ability

• World Health Organization: Ageing and Health

• World Health Organization: Physical Activity

• NHS: Hormone Replacement Therapy

• National Human Genome Research Institute: Direct-to-Consumer Genetic Testing

• FDA: Bulk Drug Substances That May Present Significant Safety Risks

• FDA: Consumer Alert on Regenerative Medicine Products